Santen Pharmaceutical Co. Ltd.

12.702+0.2760+2.22%Vol 2.83K1Y Perf -22.13%
Dec 8th, 2021 14:07
BID0.0000 ASK0.0000
Open12.570 Previous Close12.426
Pre-Market- After-Market-
 - -%  - -
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★+     44.28
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★+     43.26
Price Range Ratio 52W %
6.48 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha0.00 Standard Deviation0.07
Beta-0.13 

Today's Price Range

12.57012.702

52W Range

12.41816.800

5 Year PE Ratio Range

10.10036.800

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-2.17%
1 Month
-12.98%
3 Months
-20.75%
6 Months
-9.17%
1 Year
-22.13%
3 Years
-15.47%
5 Years
6.21%
10 Years
0.00%

TickerPriceChg.Chg.%
SNPHF12.7020.27602.22
AAPL175.294.11002.40
GOOG2 969.398.66000.29
MSFT332.78-2.1400-0.64
XOM62.350.08000.13
WFC49.41-0.8400-1.67
JNJ164.040.68000.42
FB331.018.20002.54
GE98.320.77000.79
JPM160.85-1.7200-1.06
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2.83K
Shares Outstanding0
Shares Float399.85M
Trades Count4
Dollar Volume16.70K
Avg. Volume1.25K
Avg. Weekly Volume1.04K
Avg. Monthly Volume1.25K
Avg. Quarterly Volume754
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Santen Pharmaceutical Co. Ltd.

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

CEO:

Telephone: +81 663217000

Address: Grand Front Osaka Tower A, Osaka 530-8552, , JPN

Number of employees: 4 073

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

0%100%

Bearish Bullish

38%62%

Bearish Bullish

50%50%

News